Epigral

Market Cap: Small Cap
Industry: Specialty Chemicals
ISIN: INE071N01016
NSEID: EPIGRAL
BSEID: 543332
View on NSE | View on BSE

INR

1,114.90

51.25 (4.82%)

BSENSE

Jun 12, 03:30 PM

BSE+NSE Vol: 37.93 k

{
  "main_header": {
    "sid": 1003523,
    "name": "Epigral",
    "stock_name": "Epigral",
    "full_name": "Epigral Ltd",
    "name_url": "stocks-analysis/epigral",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,114.90",
    "chg": 51.25,
    "chgp": "4.82%",
    "dir": 1,
    "prev_price": "1,063.65",
    "mcapval": "4,690.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543332,
    "symbol": "EPIGRAL",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "sector_id": 74,
    "indexname": "India SENSEX",
    "isin": "INE071N01016",
    "curr_date": "Jun 12, 03:30 PM",
    "curr_time": "14:17 PM",
    "last_traded_at": "Jun 12, 03:30 PM IST",
    "bse_nse_vol": "37.93 k",
    "exc_status": "Active",
    "traded_date": "Jun 12, 2026",
    "traded_date_str": "2026 06 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/epigral-1003523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-4052734",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EpigralLtd_mojoScore_4052734.png",
        "date": "2026-06-14 10:10:29",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-4033427",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/EpigralLtd_mojoScore_4033427.png",
        "date": "2026-06-03 10:11:38",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-4007829",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EpigralLtd_mojoScore_4007829.png",
        "date": "2026-05-23 10:10:32",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-4007812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EpigralLtd_mojoScore_4007812.png",
        "date": "2026-05-23 10:10:32",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 May 2026, providing investors with an up-to-date view of its performance and outlook."
      },
      {
        "title": "Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Specialty Chemicals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-specialty-chemicals-sector-4004265",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EpigralLtd_valuationdot_4004265.png",
        "date": "2026-05-22 08:01:17",
        "description": "Epigral Ltd has witnessed a notable improvement in its valuation parameters, shifting from very attractive to attractive territory, despite ongoing challenges in the specialty chemicals sector. This recalibration reflects a more balanced price-to-earnings (P/E) and price-to-book value (P/BV) ratio relative to its historical averages and peer group, signalling a potential inflection point for investors assessing the stock’s price attractiveness."
      },
      {
        "title": "Epigral Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-3987263",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EpigralLtd_mojoScore_3987263.png",
        "date": "2026-05-12 10:11:08",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance."
      },
      {
        "title": "Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-sector-challenges-3984743",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EpigralLtd_valuationdot_3984743.png",
        "date": "2026-05-11 08:02:36",
        "description": "Epigral Ltd, a small-cap player in the specialty chemicals sector, has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change comes amid a backdrop of mixed market returns and a sector characterised by expensive peer valuations, positioning Epigral as a potentially compelling investment opportunity despite recent share price volatility."
      },
      {
        "title": "Epigral Ltd’s Mixed Week: -0.09% Price Change Amid Valuation Shifts and Financial Strains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltds-mixed-week--009-price-change-amid-valuation-shifts-and-financial-strains-3983032",
        "imagepath": "",
        "date": "2026-05-09 11:05:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Intraday high surge to Rs.1,378 (+15.35%)</p>\n                    <p><strong>4 May:</strong> Mixed quarterly results with record sales but declining PAT</p>\n                    <p><strong>5 May:</strong> Valuation metrics improve, signalling attractive price levels</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.1,327.55 (-0.09%) vs Sensex +1.25%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,328.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value..."
      },
      {
        "title": "Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Specialty Chemicals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-specialty-chemicals-sector-3974691",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/EpigralLtd_valuationdot_3974691.png",
        "date": "2026-05-05 08:01:37",
        "description": "Epigral Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a recalibration of price attractiveness within the specialty chemicals sector. This change comes amid a strong price rally and improved relative valuation metrics compared to its peers, signalling potential opportunities for investors despite a cautious overall market stance."
      }
    ],
    "total": 620,
    "sid": "1003523",
    "stock_news_url": "https://www.marketsmojo.com/news/epigral-1003523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "10-Jun-2026",
      "details": "Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investor / Analyst on June 16 2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "09-Jun-2026",
      "details": "Submission of Scrutinizers Report of 19th AGM held on 08.06.2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "08-Jun-2026",
      "details": "Proceedings of 19th AGM held on 08.06.2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Epigral Ltd has declared <strong>50%</strong> dividend, ex-date: 01 Jun 26",
          "dt": "2026-06-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Epigral Ltd is Rated Sell

2026-06-14 10:10:29

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Epigral Ltd is Rated Sell

2026-06-03 10:11:38

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Epigral Ltd is Rated Sell

2026-05-23 10:10:32

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Epigral Ltd is Rated Sell

2026-05-23 10:10:32

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 May 2026, providing investors with an up-to-date view of its performance and outlook.

Read full news article

Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Specialty Chemicals Sector

2026-05-22 08:01:17

Epigral Ltd has witnessed a notable improvement in its valuation parameters, shifting from very attractive to attractive territory, despite ongoing challenges in the specialty chemicals sector. This recalibration reflects a more balanced price-to-earnings (P/E) and price-to-book value (P/BV) ratio relative to its historical averages and peer group, signalling a potential inflection point for investors assessing the stock’s price attractiveness.

Read full news article

Epigral Ltd is Rated Sell by MarketsMOJO

2026-05-12 10:11:08

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.

Read full news article

Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges

2026-05-11 08:02:36

Epigral Ltd, a small-cap player in the specialty chemicals sector, has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change comes amid a backdrop of mixed market returns and a sector characterised by expensive peer valuations, positioning Epigral as a potentially compelling investment opportunity despite recent share price volatility.

Read full news article

Epigral Ltd’s Mixed Week: -0.09% Price Change Amid Valuation Shifts and Financial Strains

2026-05-09 11:05:59

Key Events This Week

4 May: Intraday high surge to Rs.1,378 (+15.35%)

4 May: Mixed quarterly results with record sales but declining PAT

5 May: Valuation metrics improve, signalling attractive price levels

8 May: Week closes at Rs.1,327.55 (-0.09%) vs Sensex +1.25%

Week Open

Rs.1,328.80

Week Close

Read full news article

Epigral Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Specialty Chemicals Sector

2026-05-05 08:01:37

Epigral Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a recalibration of price attractiveness within the specialty chemicals sector. This change comes amid a strong price rally and improved relative valuation metrics compared to its peers, signalling potential opportunities for investors despite a cautious overall market stance.